Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Evelo Biosciences, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues20.09.1
            Revenue growth118.5% 
Cost of goods sold27.513.0
Gross profit-7.6-3.9
            Gross margin-38.0%-42.6%
General and administrative7.63.9
EBIT-27.5-13.0
            EBIT margin-138.0%-142.6%
Pre-tax income-28.0-13.3
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-34.1-15.0
            Net margin-171.0%-164.0%
 
Diluted EPS($9.10)($5.28)
Shares outstanding (diluted)3.82.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy